Maitalon 30/21+7

Drospirenone, the active ingredient in Maitalon 30/21+7, is a combined oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus. GNH USA supplies Maitalon 30/21+7 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maitalon 30/21+7, a combined oral contraceptive, is used to prevent pregnancy by modulating the hormonal axis.

Prevention of pregnancy: provides reliable contraceptive protection for women of childbearing potential. Regulation of menstrual bleeding: helps achieve more predictable cycle length and flow. Management of acne: reduces androgen‑driven skin lesions in many users.

Maitalon 30/21+7 may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort. - Weight gain: modest fluid retention. - Mood changes: irritability or mild depression. - Spotting: irregular breakthrough bleeding.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in legs. - Pulmonary embolism: clot migration to lungs. - Stroke: cerebrovascular accident, especially in high‑risk groups. - Myocardial infarction: heart attack risk in smokers over 35. - Severe hypertension: sudden rise in blood pressure. - Liver tumor: rare hepatic adenoma development.

Before prescribing Maitalon 30/21+7, clinicians should evaluate several safety factors.

Contraindications: known thromboembolic disorders, current pregnancy, or active breast cancer. Smoking: avoid use in women over 35 who smoke regularly. Cardiovascular risk: assess history of hypertension, stroke, or myocardial infarction. Liver disease: use with caution in patients with hepatic impairment. Drug interactions: review concomitant medications for potential efficacy loss. Store at room temperature: keep in the original pack, protect from moisture and heat.

Maitalon 30/21+7 can interact with several medicines that alter hormone levels or clotting risk.

Major Interactions (Avoid): - Antiepileptics (e.g., carbamazepine, phenytoin): markedly reduce contraceptive effectiveness. - Rifampin: induces hepatic enzymes, decreasing hormone concentrations. - St. John's wort: herbal inducer that lowers oral contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline): may slightly diminish protection. - SSRIs (e.g., fluoxetine): can increase hormone levels, requiring monitoring.